The legal library gives you easy access to the FTC’s case information and other official legal, policy, and guidance documents.
0502005 Informal Interpretation
Granting of Request for Early Termination of the Waiting Period Under the Premerger Notification Rules
Genzyme Corporation and Ilex Oncology, Inc., In the Matter of
A consent order allowed Genzyme’s acquisition of ILEX Oncology, Inc., but requires the companies to divest certain assets in the market for solid organ transplant acute therapy drugs. Specifically, Genzyme is required to divest all contractual rights related to ILEX’s Campath®, an immunosuppressant antibody used in solid organ transplants to Schering AG.